Molecular subtypes of BC are identified based on the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the concentration of the Ki-67 antigen, a marker of cell proliferation [31,32,33]. The gene discussed is ERBB2; the disease is breast cancer.